Skip to main content

Table 5 Scores on primary, secondary, and explanatory outcome measures by intervention group across evaluation time points

From: Community-based exercise programs incorporating healthcare-community partnerships to improve function post-stroke: feasibility of a 2-group randomized controlled trial

Measure (score range)

Immediate Group (8 participants, 6 caregivers)

Scores are median (P25, P75)

Waitlist Group (13 participants, 5 caregivers)

Scores are median (P25, P75)

Baseline

3 months

6 months

10 months

Baseline

3 months

6 months

10 months

n

Score

n

Score

n

Score

n

Score

n

Score

n

Score

n

Score

n

Score

SIPSO Physical (0–20)

7

5 (3, 15)

8

8 (3, 16)*

8

7 (3, 16)*

7

7 (5, 16)

13

11 (9, 16)

13

11 (10, 16)

13

11 (5, 16)

10

14 (9, 16)

SIPSO Social (0–20)

8

14 (11, 15)

8

12 (10, 14)

8

14 (10, 16)

7

14 (8, 14)

13

14 (9, 17)

13

13 (9, 16)

13

12 (8, 14)

10

12 (9, 14)

NEADL (0–66)

8

31 (15, 52)

7

28 (12, 51)

6

30 (17, 53)

7

32 (16, 49)

13

39 (29, 53)

10

49 (25, 53)

10

43 (23, 53)

11

41 (35, 50)

LSA (0–120)

8

44 (27, 62)

8

41 (23, 72)

7

33 (29, 78)

7

34 (12, 54)

12

39 (21, 61)

13

29 (17, 52)

12

39 (22, 45)

10

40 (27, 69)

Barthel index (0–100)

7

80 (50, 100)

7

95 (75, 100)

8

90 (51, 98)

7

95 (75, 100)

12

95 (81, 99)

13

95 (83, 100)

13

95 (71, 100)

11

95 (85, 100)

SIS Physical (4–20)

8

10 (8, 15)

8

10 (9, 15)

8

10 (8, 16)

7

11 (8, 16)

13

12 (10, 15)

13

14 (11, 16)

12

12 (9, 14)

10

13 (9, 16)

SIS Memory (7–35)

8

32 (26, 34)

7

32 (27, 35)

8

31 (27, 35)

7

33 (26, 35)

13

29 (26, 35)

13

29 (27, 34)

13

29 (23, 32)

10

30 (30, 31)

SIS Mood (9–45)

8

33 (32, 34)

8

33 (28, 37)

8

32 (3, 35)

7

31 (30, 33)

13

33 (30, 35)

13

31 (29, 33)

13

33 (30, 36)

10

33 (28, 34)

SIS Communication (7–35)

8

30 (26, 35)

7

32 (26, 35)

8

33 (29, 35)

7

32 (26, 35)

12

30 (25, 35)

13

32 (26, 35)

13

31 (25, 34)

10

33 (29, 34)

SIS ADL (10–50)

7

31 (26, 45)

6

34 (23, 35)

8

33 (22, 46)

7

31 (24, 45)

13

39 (31, 44)

12

42 (35, 46)

13

39 (24, 48)

10

42 (38, 44)

SIS Mobility (9–45)

8

32 (24, 40)

8

34 (26, 41)

8

30 (26, 37)

7

32 (29, 34)

13

35 (28, 39)

12

35 (26, 41)

12

31 (28, 39)

10

39 (28, 42)

SIS Hand Function (5–25)

8

10 (5, 23)

8

17 (8, 23)

8

13 (6, 20)

7

11 (6, 24)

13

17 (11, 20)

12

18 (13, 22)

13

18 (13, 21)

10

18 (14, 22)

SIS Participation (8–40)

7

21 (17, 35)

8

32 (18, 34)

8

23 (15, 33)

7

35 (18, 37)

13

28 (24, 34)

12

34 (25, 38)

13

30 (28, 36)

10

27 (20, 33)

SIS Recovery VAS (0-100)

6

40 (28, 90)

8

63 (46, 90)

8

50 (20, 94)

7

60 (50, 90)

9

75 (53, 85)

9

70 (53, 78)

13

70 (53, 85)

10

80 (58, 90)

EQ-5D-5L Health Utility

7

0.5 (0.4, 0.7)

8

0.7 (0.6, 0.8)

8

0.6 (0.5, 0.7)

7

0.6 (0.5, 0.8)

13

0.8 (0.6, 0.9)

13

0.7 (0.6, 0.8)

13

0.8 (0.5, 0.8)

10

0.8 (0.5, 0.8)

EQ-5D-5L VAS (0–100)

7

60 (50, 75)

8

80 (70, 94)

8

78 (40, 84)

7

75 (50, 85)

12

70 (62, 75)

12

80 (67, 84)

13

80 (50, 80)

10

80 (50, 83)

CAS (0-102)

6

52 (31, 84)

6

53 (35, 78)

6

52 (34, 83)

5

33 (16, 55)

5

54 (32, 71)

5

78 (33, 84)

5

57 (25, 75)

4

60 (38, 82)

RAND Emotion (0–100)

6

62 (57, 76)

6

64 (55, 64)

6

70 (61, 76)

5

74 (49, 84)

4

62 (59, 68)

5

76 (64, 84)

5

56 (52, 76)

4

64 (40, 64)

RAND Fatigue (0–100)

6

43 (25, 49)

6

33 (26, 39)

6

35 (47, 43)

5

53 (41, 68)

4

50 (44, 55)

5

35 (30, 40)

5

50 (30, 55)

4

50 (30, 75)

Berg Balance Scale (0-56)

8

35 (22, 48)

7

40 (33, 50)

7

49 (26, 52)

7

45 (26, 51)

13

44 (27, 49)

13

47 (30, 52)

11

46 (23, 52)

11

48 (38, 52)

ABC Scale (0–100)

7

39 (28, 76)

8

61 (32, 79)

8

49 (32, 71)

7

53 (34, 83)

12

65 (57, 82)

12

72 (60, 91)

13

63 (34, 77)

10

69 (53, 83)

30-sec Sit to Stand

8

3 (0, 8)

7

6 (2, 9)

7

5 (0, 7)

6

6 (0, 9)

12

6 (2, 8)

13

6 (0, 10)

11

5 (4, 9)

10

7 (3, 9)

10-m walk test (m/s)

8

0.5 (0.1, 0.9)

8

0.5 (0.1, 1.2)

7

0.5 (0.1, 1.1)

7

0.3 (0.1, 0.9)

13

0.7 (0.5, 0.9)

13

0.8 (0.5, 1.1)

11

0.7 (0.3, 0.8)

11

0.8 (0.6, 1.1)

6-min walk test (m)

8

157 (37, 320)

8

130 (102, 300)

7

201 (82, 300)

6

120 (95, 300)

13

241 (191, 299)

13

180 (112, 300)

11

174 (132, 300)

10

179 (114, 364)

Trail making test A (sec)

8

56 (45, 188)

8

56 (46, 275)

7

47 (42, 95)

7

49 (44, 120)

13

65 (38, 90)

11

61 (43, 121)

12

51 (40, 170)

11

54 (36, 96)

Trail making test B (sec)

8

169 (85, 300)

8

130 (102, 300)

7

167 (62, 298)

7

120 (95, 300)

13

202 (101, 300)

11

180 (112, 300)

12

158 (130, 300)

11

142 (92, 300)

GDS (0–15) No. (%)

8

 

8

 

8

 

7

 

12

 

12

 

13

 

10

 

 Normal (0–4)

 

0 (0)

 

1 (13)

 

0 (0)

 

1 (13)

 

0 (0)

 

2 (15)

 

1 (8)

 

0 (0)

 Mild (5–8)

 

6 (75)

 

6 (75)

 

5 (63)

 

3 (38)

 

6 (54)

 

6 (46)

 

9 (69)

 

7 (70)

 Moderate (9–11)

 

2 (25)

 

1 (13)

 

2 (25)

 

2 (25)

 

2 (15)

 

4 (31)

 

3 (23)

 

3 (30)

 Severe (12–15)

 

0 (0)

 

0 (0)

 

1 (13)

 

1 (13)

 

4 (31)

 

0 (0)

 

0 (0)

 

0 (0)

  1. Abbreviations: SIPSO subjective index of physical and social outcome, NEADL Nottingham extended activities of daily living, LSA lifespace assessment, SIS stroke impact scale, ADL activities of daily living, VAS visual analog scale, EQ-5D-5L EuroQol-5D, five-level, CAS caregiver assessment scale, ABC activities-specific balance confidence, GDS geriatric depression scale. Within each timeline column, the first sub-collumn represents the number of participants for which data were available
  2. Bolded values reflect median scores at 3, 6, and 10 months that were improved compared to baseline